Gatilon

Next-generation fluoroquinolone based on gatifloxacin for the treatment of respiratory diseases of bacterial etiology in poultry and pigs

High sensitivity of field strains of APP pathogens, bronchitis and mycoplasma infections
Overcomes resistance to previous generations of fluoroquinolones
Purposefully accumulates and persists for a long time in the tissues of the respiratory system, which provides a prolonged effect
Effective in rotation with florfenicol-based drugs
Does not reduce the water consumption

Composition

Pharmacological properties

Indications

Dosage and method of administration

Restrictions

1 ml Gatilon

gatifloxacin 100 mg

Please note: The information given on this page is for an informative purpose only. Product characteristics, packaging, label design and overall appearance may vary in different regions. Contact our representatives for more information.

Pharmacological properties

Gatilon belongs to the pharmacotherapeutic group of fluoroquinolones. Gatifloxacin has a bactericidal effect on the microorganisms, including:

Acinetobacter spp.
Actinobacillus pleuropneumoniae
Actinobacillus spp.
Aeromonas spp.
Arcanobacterium spp.
Bacillus spp.
Bacteroides fragilis
Bacteroides spp.
Bordetella spp.
Borrelia spp. (spirochaetes)
Brachyspira hyodysenteriae
Brachyspira pilosicoli.
Brachyspira spp.
Campylobacter spp.
Chlamydia pneumoniae
Chlamydia psittaci
Chlamydia spp.
Citrobacter spp.
Clostridium perfringens
Clostridium spp.
Corynebacterium spp.
Enterobacter spp.
Enterococcus spp.
Escherichia coli
Fusobacterium spp.
Haemophilus ducreyi
Haemophilus influenzae
Haemophilus parainfluenzae
Haemophilus spp.

Klebsiella spp.
Leptospira spp.
Listeria monocytogenes
Listeria spp.
Moraxella catarrhalis β+/ β-
Moraxella spp.
Morganella morganii
Morganella spp.
Mycobacterium spp.
Mycoplasma pneumoniae
Mycoplasma spp.
Neisseria spp.
Pasteurella spp.
Peptostreptococcus spp.
Proteus mirabilis
Proteus spp.
Proteus vulgaris
Providencia spp.
Pseudomonas spp.
Rickettsia spp.
Salmonella spp.
Serratia spp.
Staphylococcus aureus
Staphylococcus spp.
Streptococcus agalactiae
Streptococcus dysgalactiae
Streptococcus spp.
Streptococcus suis
Streptococcus uberis
Ureaplasma spp.

Indications

Gatilon is used in pigs, broilers and replacement chickens for the treatment of bacterial infections:

in pigs: to treat bacterial diseases of the respiratory system (including actinobacillar pleuropneumonia, enzootic pneumonia, streptococcal pneumonia), gastrointestinal tract (including salmonellosis, colibacteriosis), genitourinary system, skin and soft tissue infections caused by pathogens sensitive to gatifloxacin, as well as spirochaetosis, streptococcosis, pseudomoniasis and mycoplasma infections.
in broilers and replacement chickens: to treat mycoplasmosis, salmonellosis, colibacteriosis, dysentery, necrotizing enteritis, pseudomoniasis, campylobacteriosis, staphylococcosis, pasteurellosis and other diseases caused by pathogens sensitive to gatifloxacin.

Dosage and method of administration

Specie

Method of administration

Dosage

Treatment course

Pigs

Poultry

Orally, individually or by a group method with drinking water

0.1 ml/1 kg of animal

body weight (10 mg of gatifloxacin/1 kg of animal body weight)

Once a day for 2-3 days.

In case of complex and mixed infections, the drug can be administered for up to 5 days.

Restrictions

Contraindications and special instructions:
Avoid using the drug in laying hens and replacement chickens less than 16 days before laying, as gatifloxacin accumulates in eggs. The use in newborn piglets, lactating and pregnant sows is advised to be under the supervision of a veterinarian based on an assessment of the ratio of the expected benefit to the possible risk of its use.

Withdrawal period:
meat: 14 days (pigs), 16 days (poultry)
eggs: 16 days

Gatilon

Similar products